Lv1
78 积分 2024-12-23 加入
The endosomal-lysosomal system in ADC design and cancer therapy
28天前
已完结
INA03: A Potent Transferrin-Competitive Antibody–Drug Conjugate against CD71 for Safer Acute Leukemia Treatment
1个月前
已完结
Discovery and Characterization of RP03707: A Highly Potent and Selective KRASG12D PROTAC
1个月前
已完结
The Discovery of Exarafenib (KIN-2787): Overcoming the Challenges of Pan-RAF Kinase Inhibition
1个月前
已完结
A patent review of BRD4 inhibitors (2020–present)
1个月前
已完结
Elucidating Critical Factors of Internalization and Drug Release of Antibody-Drug Conjugates (ADCs) Using Kinetic Parameters Evaluated by a Novel Tool Named TORCH
1个月前
已完结
Small-molecule mTOR inhibitors in the clinic: From bench to bedside
1个月前
已完结
The MEK–RAF molecular glue IK-595 has potent antitumor activity across RAS/MAPK pathway-altered cancers
1个月前
已完结
Discovery of a Potent and Selective Tyrosine Kinase 2 Inhibitor: TAK-279
3个月前
已完结
CD6-targeted antibody-drug conjugate as a new therapeutic agent for T cell lymphoma
5个月前
已完结
皖公网安备34019202002308
